Several studies have proven that cancer detection rates were 11.8-20.5%, 20.5-25.0%, and 47.1-53.0% in the PSA range of 4-10 ng/mL, 10-20 ng/mL, and greater than 20 ng/mL, respectively [1–3]. The gene discussed is KLK3; the disease is cancer.